Renal Cancers Active Not Recruiting Phase 1 / 2 Trials for Durvalumab (DB11714)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02118337A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced MalignanciesTreatment